Heartland Advisors Inc. Boosts Stake in The Cooper Companies, Inc. $COO

Heartland Advisors Inc. raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 18.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 221,656 shares of the medical device company’s stock after acquiring an additional 34,393 shares during the quarter. Heartland Advisors Inc.’s holdings in Cooper Companies were worth $15,848,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Root Financial Partners LLC increased its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. lifted its stake in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares during the last quarter. True Wealth Design LLC lifted its stake in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the last quarter. Cromwell Holdings LLC boosted its position in Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares in the last quarter. Finally, Board of the Pension Protection Fund bought a new stake in Cooper Companies during the fourth quarter valued at about $41,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have commented on COO shares. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Stifel Nicolaus cut their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. BNP Paribas Exane reduced their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, June 8th. Finally, Needham & Company LLC decreased their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $81.85.

Cooper Companies Trading Down 1.9%

Shares of NASDAQ:COO opened at $71.71 on Friday. The business’s 50-day moving average is $66.24 and its 200 day moving average is $72.58. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The firm has a market capitalization of $13.99 billion, a P/E ratio of 60.77, a P/E/G ratio of 1.87 and a beta of 0.84. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.